Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
3
×
life sciences
national blog main
clinical trials
deals
fda
gene therapy
genentech
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
10x genomics
480 biomedical
abbvie
acetylon pharmaceuticals
allergan
ambys medicines
amgen
anemia
antibiotic
arsenal medical
astrazeneca
autism
autism spectrum disorder
avexis
biogen
bob langer
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
What
biotech
3
×
new
aiming
ambys
august
big
bio
busy
company
control
days
deadly
deal
debut
debuted
decisions
developing
devices
diseases
drugs
fda
formed
future
ipo
late
launch
legacy
liver
lyra
make
markets
medicines
million
news
nods
nose
noses
opioid
past
persistently
Language
unset
Current search:
ipo
×
biotech
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
